Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1993 4
1994 4
1995 3
1996 6
1998 3
1999 1
2001 3
2002 1
2013 1
2016 1
2020 2
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Sexual quality of life is impaired in patients with chronic hepatitis C.
Vergniol J, Duc S, Hou G, Hiriart JB, Foucher J, Chenus F, Fabères C, Chermak F, Lafournière A, Souakri N, de Lédinghen V. Vergniol J, et al. Among authors: faberes c. Int J Impot Res. 2016 Mar-Apr;28(2):68-73. doi: 10.1038/ijir.2016.5. Epub 2016 Feb 11. Int J Impot Res. 2016. PMID: 26865102
Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients.
Etienne G, Dulucq S, Bauduer F, Adiko D, Lifermann F, Dagada C, Lenoir C, Schmitt A, Klein E, Madene S, Fort MP, Bijou F, Moldovan M, Turcq B, Robbesyn F, Durrieu F, Versmée L, Katsahian S, Faberes C, Lascaux A, Mahon FX. Etienne G, et al. Among authors: faberes c. Cancers (Basel). 2020 Sep 4;12(9):2521. doi: 10.3390/cancers12092521. Cancers (Basel). 2020. PMID: 32899879 Free PMC article.
Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.
Etienne G, Faberes C, Bauduer F, Adiko D, Lifermann F, Dagada C, Lenoir C, Schmitt A, Klein E, Fort MP, Bijou F, Turcq B, Robbesyn F, Durrieu F, Versmée L, Madene S, Moldovan M, Katsahian S, Charles-Nelson A, Lascaux A, Mahon FX, Dulucq S. Etienne G, et al. Among authors: faberes c. Cancer Med. 2021 Jun;10(11):3635-3645. doi: 10.1002/cam4.3921. Epub 2021 May 14. Cancer Med. 2021. PMID: 33988316 Free PMC article.
Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma.
Marit G, Faberes C, Pico JL, Boiron JM, Bourhis JH, Brault P, Bernard P, Foures C, Cony-Makhoul P, Puntous M, Vezon G, Broustet A, Girault D, Reiffers J. Marit G, et al. Among authors: faberes c. J Clin Oncol. 1996 Apr;14(4):1306-13. doi: 10.1200/JCO.1996.14.4.1306. J Clin Oncol. 1996. PMID: 8648388 Clinical Trial.
Autografting in chronic myeloid leukemia: an overview.
Reiffers J, Mahon FX, Boiron JM, Fabères C, Marit G, Cony-Makhoul P, Broustet A. Reiffers J, et al. Among authors: faberes c. Leukemia. 1996 Mar;10(3):385-8. Leukemia. 1996. PMID: 8642851 Review.
A French national survey on the use of antibiotic prophylaxis in cirrhotic patients.
Thevenot T, Degand T, Grelat N, Elkrief L, Christol C, Moreau R, Henrion J, Cadranel JF, Sheppard F, Bureau C, di Martino V, Pauwels A; National Association of General Hospital Hepatogastroenterologists. Thevenot T, et al. Liver Int. 2013 Mar;33(3):389-97. doi: 10.1111/liv.12093. Epub 2013 Jan 10. Liver Int. 2013. PMID: 23302021
A single center evaluation of cost savings related to treatment-free remission in chronic myeloid leukemia patients: the prerequisites of a pharmaco-economy larger study.
Etienne G, Dulucq S, Faberes C, Bijou F, Schmitt A, Klein E, Fort MP, Durrieu F, Toulza E, Mahon FX. Etienne G, et al. Among authors: faberes c. Br J Haematol. 2020 May;189(3):e97-e100. doi: 10.1111/bjh.16511. Epub 2020 Feb 10. Br J Haematol. 2020. PMID: 32043283 Free article. No abstract available.
33 results